New preprint from the lab! Profiling triple negative breast cancer samples over time, we looked at tumour genome responses to treatment. We reveal major roles for whole genome duplication (WGD) as these tumours evolve; with WGD seen in many pre-treatment samples, but also re-emerging at recurrence.